购物车
全部删除
您的购物车当前为空
别名 腺苷钴胺, Coenzyme B12, Cobamamide, AdoCbl
Adenosylcobalamin (AdoCbl) 是一种 Vitamin B12的特性形式,其中 Vitamin B12 是是甲基丙二酰 CoA 突变酶的辅助因子。


为众多的药物研发团队赋能,
让新药发现更简单!
Adenosylcobalamin (AdoCbl) 是一种 Vitamin B12的特性形式,其中 Vitamin B12 是是甲基丙二酰 CoA 突变酶的辅助因子。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 5 mg | ¥ 112 | 现货 | |
| 10 mg | ¥ 143 | 现货 | |
| 25 mg | ¥ 210 | 现货 | |
| 50 mg | ¥ 315 | 现货 | |
| 100 mg | ¥ 490 | 现货 | |
| 200 mg | ¥ 695 | 现货 | |
| 500 mg | ¥ 1,170 | 现货 | |
| 1 mL x 10 mM (in DMSO) | ¥ 228 | 现货 |
Adenosylcobalamin 相关产品
| 产品描述 | Adenosylcobalamin (AdoCbl) is a biologically active form of vitamin B12 .It is a cofactor for methylmalonyl CoA mutase. It belongs to the corrinoid group of compounds, which contain a corrin macrocycle, and is produced only by certain bacteria and archaea. It is a cofactor for various enzymes including mutases, eliminases, aminomutases, and a reductase. |
| 体外活性 | Adenosylcobalamin作为一组酶的辅因子,这些酶催化不寻常的重排或消除反应[1]。 |
| 别名 | 腺苷钴胺, Coenzyme B12, Cobamamide, AdoCbl |
| 分子量 | 1579.58 |
| 分子式 | C72H100CoN18O17P |
| CAS No. | 13870-90-1 |
| Smiles | Nc1ncnc2n(cnc12)[C@H]1O[C@H](C[Co++])[C@H](O)[C@@H]1O.[H][C@]12[N-]\C(=C(C)/C3=N/C(=C\C4=N\C(=C(C)/C5=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]5CCC(N)=O)\[C@@](C)(CC(N)=O)[C@@H]4CCC(N)=O)/C(C)(C)[C@@H]3CCC(N)=O)[C@](C)(CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)n1cnc3cc(C)c(C)cc13)[C@H]2CC(N)=O |
| 密度 | no data available |
| 存储 | keep away from direct sunlight,keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| 溶解度信息 | H2O: 4 mg/mL (2.53 mM), Sonication is recommended. DMSO: 41 mg/mL (25.96 mM) | ||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (1.27 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
H2O/DMSO
DMSO
| |||||||||||||||||||||||||||||||
评论内容